| - GRCh37:
- Chr1:201063077
- GRCh38:
- Chr1:201093949
| CACNA1S | | Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Likely benign (Mar 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201054177
- GRCh38:
- Chr1:201085049
| CACNA1S | | Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Likely benign (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201038344
- GRCh38:
- Chr1:201069216
| CACNA1S | | Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Likely benign (Aug 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201052336
- GRCh38:
- Chr1:201083208
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1 | Likely benign (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201031657
- GRCh38:
- Chr1:201062529
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1 | Likely benign (Feb 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201061082
- GRCh38:
- Chr1:201091954
| CACNA1S | | Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely benign (Jun 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201060929
- GRCh38:
- Chr1:201091801
| CACNA1S | | Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely benign (Mar 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201016638
- GRCh38:
- Chr1:201047510
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely benign (Aug 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201023663
- GRCh38:
- Chr1:201054535
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely benign (Aug 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201023706
- GRCh38:
- Chr1:201054578
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely benign (May 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201018118
- GRCh38:
- Chr1:201048990
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201021695
- GRCh38:
- Chr1:201052567
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely benign (Apr 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201022421
- GRCh38:
- Chr1:201053293
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely benign (Sep 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201058369
- GRCh38:
- Chr1:201089241
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely benign (Jun 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201063163
- GRCh38:
- Chr1:201094035
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely benign (Jun 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201023707
- GRCh38:
- Chr1:201054579
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely benign (Aug 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201009430
- GRCh38:
- Chr1:201040302
| CACNA1S, LOC101929305 | P1767S | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Sep 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201054159
- GRCh38:
- Chr1:201085031
| CACNA1S | G384E | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Inborn genetic diseases, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5
| Uncertain significance (Jul 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201009006
- GRCh38:
- Chr1:201039878
| CACNA1S, LOC101929305 | D1859N | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5 | Conflicting interpretations of pathogenicity (Jul 11, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201046097
- GRCh38:
- Chr1:201076969
| CACNA1S | R593Q | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Inborn genetic diseases
| Conflicting interpretations of pathogenicity (Sep 28, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201058579
- GRCh38:
- Chr1:201089451
| CACNA1S | T236M | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1 | Conflicting interpretations of pathogenicity (Oct 8, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201044743
- GRCh38:
- Chr1:201075615
| CACNA1S | V610L | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Inborn genetic diseases
| Uncertain significance (Jun 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201047212-201047225
- GRCh38:
- Chr1:201078084-201078097
| CACNA1S | N468fs | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1 | Pathogenic/Likely pathogenic (Feb 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201052449
- GRCh38:
- Chr1:201083321
| CACNA1S | R412* | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1 | Pathogenic/Likely pathogenic (May 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201047096
- GRCh38:
- Chr1:201077968
| CACNA1S | E510D | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1 | Conflicting interpretations of pathogenicity (Sep 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201013457
- GRCh38:
- Chr1:201044329
| CACNA1S | R1599Q | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201054591
- GRCh38:
- Chr1:201085463
| CACNA1S | V375F | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Oct 25, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201047196
- GRCh38:
- Chr1:201078068
| CACNA1S | T477I | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201034948
- GRCh38:
- Chr1:201065820
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5 | Conflicting interpretations of pathogenicity (Jul 19, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201010665
- GRCh38:
- Chr1:201041537
| CACNA1S, LOC101929305 | G1701R | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1 | Uncertain significance (Jun 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201031053
- GRCh38:
- Chr1:201061925
| CACNA1S | | Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Oct 23, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201046094
- GRCh38:
- Chr1:201076966
| CACNA1S | R594L | Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Conflicting interpretations of pathogenicity (Jun 28, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201022636
- GRCh38:
- Chr1:201053508
| CACNA1S | R1249Q | Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Inborn genetic diseases, not provided | Conflicting interpretations of pathogenicity (Aug 15, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201054106
- GRCh38:
- Chr1:201084978
| CACNA1S | A402S | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, not provided, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
| Conflicting interpretations of pathogenicity (Jul 5, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201063068
- GRCh38:
- Chr1:201093940
| CACNA1S | Q114K | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Jul 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201058480
- GRCh38:
- Chr1:201089352
| CACNA1S | N269S | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Feb 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201043740
- GRCh38:
- Chr1:201074612
| CACNA1S | L653F | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Mar 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201035046
- GRCh38:
- Chr1:201065918
| CACNA1S | I925V | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Inborn genetic diseases, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
| Conflicting interpretations of pathogenicity (Jun 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201021680
- GRCh38:
- Chr1:201052552
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, not provided, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
| Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201016671
- GRCh38:
- Chr1:201047543
| CACNA1S | V1509I | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Conflicting interpretations of pathogenicity (Oct 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201017736
- GRCh38:
- Chr1:201048608
| CACNA1S | R1472H | Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, not provided
| Conflicting interpretations of pathogenicity (Aug 9, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201047074
- GRCh38:
- Chr1:201077946
| CACNA1S | A518T | Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, not provided | Uncertain significance (Sep 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201030583
- GRCh38:
- Chr1:201061455
| CACNA1S | A1023T | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, not provided, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
| Conflicting interpretations of pathogenicity (Aug 28, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201031203
- GRCh38:
- Chr1:201062075
| CACNA1S | | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Benign/Likely benign (Oct 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201020104-201020105
- GRCh38:
- Chr1:201050976-201050977
| CACNA1S | | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201035053
- GRCh38:
- Chr1:201065925
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely benign (Jul 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201031648
- GRCh38:
- Chr1:201062520
| CACNA1S | | Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely benign (Oct 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201009187
- GRCh38:
- Chr1:201040059
| CACNA1S, LOC101929305 | | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Likely benign (Apr 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201018237
- GRCh38:
- Chr1:201049109
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely benign (Apr 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201052381
- GRCh38:
- Chr1:201083253
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely benign (Oct 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201035454
- GRCh38:
- Chr1:201066326
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely benign (Aug 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201039490
- GRCh38:
- Chr1:201070362
| CACNA1S | R757Q | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Conflicting interpretations of pathogenicity (Jul 19, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201058451
- GRCh38:
- Chr1:201089323
| CACNA1S | G279S | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Hypokalemic periodic paralysis, type 1, not provided | Conflicting interpretations of pathogenicity (Sep 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201079386
- GRCh38:
- Chr1:201110258
| CACNA1S | T55M | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Inborn genetic diseases, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1
| Conflicting interpretations of pathogenicity (Nov 18, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201020200
- GRCh38:
- Chr1:201051072
| CACNA1S | S1342L | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, not provided
| Uncertain significance (Oct 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201036025
- GRCh38:
- Chr1:201066897
| CACNA1S | M883L | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Mar 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201039487
- GRCh38:
- Chr1:201070359
| CACNA1S | P758L | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201017737
- GRCh38:
- Chr1:201048609
| CACNA1S | R1472C | Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Conflicting interpretations of pathogenicity (Jul 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201079286
- GRCh38:
- Chr1:201110158
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Oct 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201036042
- GRCh38:
- Chr1:201066914
| CACNA1S | A877V | Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
| Conflicting interpretations of pathogenicity (Sep 20, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201034960
- GRCh38:
- Chr1:201065832
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (May 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201052406
- GRCh38:
- Chr1:201083278
| CACNA1S | H426R | Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, not provided, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
| Uncertain significance (Oct 25, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201021765
- GRCh38:
- Chr1:201052637
| CACNA1S | K1291N | Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Mar 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201030513
- GRCh38:
- Chr1:201061385
| CACNA1S | I1046N | not provided, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
| Uncertain significance (Jun 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201009200
- GRCh38:
- Chr1:201040072
| CACNA1S, LOC101929305 | R1794Q | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Conflicting interpretations of pathogenicity (Sep 3, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201018231
- GRCh38:
- Chr1:201049103
| CACNA1S | | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1 | Likely benign (Sep 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201028388
- GRCh38:
- Chr1:201059260
| CACNA1S | I1152V | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Conflicting interpretations of pathogenicity (Sep 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201039515
- GRCh38:
- Chr1:201070387
| CACNA1S | E749K | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Sep 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201036117
- GRCh38:
- Chr1:201066989
| CACNA1S | T852M | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Conflicting interpretations of pathogenicity (Aug 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201034997
- GRCh38:
- Chr1:201065869
| CACNA1S | M941T | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Aug 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201041946
- GRCh38:
- Chr1:201072818
| CACNA1S | I722V | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Mar 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201022637
- GRCh38:
- Chr1:201053509
| CACNA1S | R1249W | Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
| Uncertain significance (May 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201035070
- GRCh38:
- Chr1:201065942
| CACNA1S | V917M | Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
| Uncertain significance (Aug 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201058586
- GRCh38:
- Chr1:201089458
| CACNA1S | V234M | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5 | Conflicting interpretations of pathogenicity (Oct 10, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201046215
- GRCh38:
- Chr1:201077087
| CACNA1S | N554D | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Mar 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201021733
- GRCh38:
- Chr1:201052605
| CACNA1S | R1302Q | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
| Uncertain significance (Jul 21, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201047119
- GRCh38:
- Chr1:201077991
| CACNA1S | V503M | Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Sep 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201047107
- GRCh38:
- Chr1:201077979
| CACNA1S | G507S | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Conflicting interpretations of pathogenicity (Jun 28, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201036025
- GRCh38:
- Chr1:201066897
| CACNA1S | M883V | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Conflicting interpretations of pathogenicity (Jul 19, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201081454
- GRCh38:
- Chr1:201112326
| CACNA1S | S5L | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1 | Uncertain significance (Aug 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201029866
- GRCh38:
- Chr1:201060738
| CACNA1S | W1112G | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Inborn genetic diseases, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1
| Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201044687
- GRCh38:
- Chr1:201075559
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Conflicting interpretations of pathogenicity (Aug 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201013548
- GRCh38:
- Chr1:201044420
| CACNA1S | E1569K | Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Conflicting interpretations of pathogenicity (Aug 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201009492
- GRCh38:
- Chr1:201040364
| CACNA1S, LOC101929305 | V1746A | Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, not provided
| Uncertain significance (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201061110
- GRCh38:
- Chr1:201091982
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Conflicting interpretations of pathogenicity (Aug 16, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201029944
- GRCh38:
- Chr1:201060816
| CACNA1S | R1086G | Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Dec 7, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201058520
- GRCh38:
- Chr1:201089392
| CACNA1S | I256V | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, not specified, Hypokalemic periodic paralysis, type 1 | Conflicting interpretations of pathogenicity (Jun 30, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201079325
- GRCh38:
- Chr1:201110197
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, not provided, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Benign/Likely benign (Oct 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201016695
- GRCh38:
- Chr1:201047567
| CACNA1S | T1501A | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
| Conflicting interpretations of pathogenicity (Aug 30, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201013595
- GRCh38:
- Chr1:201044467
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, not provided, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Benign/Likely benign (Oct 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201058502
- GRCh38:
- Chr1:201089374
| CACNA1S | R262W | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Uncertain significance (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201035025
- GRCh38:
- Chr1:201065897
| CACNA1S | V932M | Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Conflicting interpretations of pathogenicity (Sep 20, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201044652
- GRCh38:
- Chr1:201075524
| CACNA1S | Y640C | Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Uncertain significance (Feb 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201052338
- GRCh38:
- Chr1:201083210
| CACNA1S | I449V | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, not provided
| Conflicting interpretations of pathogenicity (Aug 15, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201016261
- GRCh38:
- Chr1:201047133
| CACNA1S | K1550N | Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Uncertain significance (Sep 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201030484
- GRCh38:
- Chr1:201061356
| CACNA1S | M1056V | Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Conflicting interpretations of pathogenicity (Aug 10, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201061232
- GRCh38:
- Chr1:201092104
| CACNA1S | V137M | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Conflicting interpretations of pathogenicity (Oct 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201063072
- GRCh38:
- Chr1:201093944
| CACNA1S | F112L | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (May 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201063104
- GRCh38:
- Chr1:201093976
| CACNA1S | A102T | Inborn genetic diseases, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
| Conflicting interpretations of pathogenicity (Jul 11, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:201079388
- GRCh38:
- Chr1:201110260
| CACNA1S | E54D | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Uncertain significance (Jul 25, 2022) | criteria provided, multiple submitters, no conflicts |